A single oral dose of celecoxib-loaded solid lipid nanoparticles for treatment of different developmental stages of experimental schistosomiasis mansoni
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A single oral dose of celecoxib-loaded solid lipid nanoparticles for treatment of different developmental stages of experimental schistosomiasis mansoni
Authors
Keywords
Schistosoma mansoni, Juvenile stage, Tegument, Celecoxib, Solid lipid nanoparticles
Journal
ACTA TROPICA
Volume 229, Issue -, Pages 106342
Publisher
Elsevier BV
Online
2022-02-12
DOI
10.1016/j.actatropica.2022.106342
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
- (2022) Eglal I. Amer et al. Biomedica
- Preparation, characterization and in vivo pharmacokinetic evaluation of curcuminoids-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs)
- (2021) Shabnam Dolatabadi et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Effect of celecoxib against different developmental stages of experimental Schistosoma mansoni infection
- (2021) Iman Fathy Abou-El-Naga et al. ACTA TROPICA
- Lipid-based nanocarrier-mediated targeted delivery of celecoxib attenuate severity of ulcerative colitis
- (2020) Rakesh Kumar Mishra et al. Materials Science & Engineering C-Materials for Biological Applications
- Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases
- (2019) Greta Volpedo et al. JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES
- Enhanced storage stability of solid lipid nanoparticles by surface modification of comb-shaped amphiphilic inulin derivatives
- (2019) Tao-Xing Peng et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis
- (2019) Eloi M. Lago et al. EBioMedicine
- A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection
- (2019) Amr Radwan et al. Parasites & Vectors
- Biological and proteomic studies of Schistosoma mansoni with decreased sensitivity to praziquantel
- (2019) Iman F. Abou-El-Naga et al. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES
- Design of colloidal drug carriers of celecoxib for use in treatment of breast cancer and leukemia
- (2019) Melike Üner et al. Materials Science & Engineering C-Materials for Biological Applications
- A journey of celecoxib from pain to cancer
- (2019) Pratiksha Saxena et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Towards elimination of schistosomiasis after 5000 years of endemicity in Egypt
- (2018) Iman F. Abou-El-Naga ACTA TROPICA
- Evaluation of nanoselenium and nanogold activities against murine intestinal schistosomiasis
- (2018) Mohamed A. Dkhil et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Evading P-glycoprotein mediated-efflux chemoresistance using Solid Lipid Nanoparticles
- (2017) Marco C. Cavaco et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor
- (2017) Shaimaa Makled et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The effect of lopinavir/ritonavir and lopinavir/ritonavir loaded PLGA nanoparticles on experimental toxoplasmosis
- (2017) Iman Fathy Abou-El-Naga et al. PARASITOLOGY INTERNATIONAL
- Effect of gold nanoparticles on mice splenomegaly induced by schistosomiasis mansoni
- (2017) Mohamed A. Dkhil et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Solid lipid nanoparticles as attractive drug vehicles: Composition, properties and therapeutic strategies
- (2016) Małgorzata Geszke-Moritz et al. Materials Science & Engineering C-Materials for Biological Applications
- Safety of Nanoparticles in Medicine
- (2015) Joy Wolfram et al. CURRENT DRUG TARGETS
- Impact of the age of Biomphalaria alexandrina snails on Schistosoma mansoni transmission: modulation of the genetic outcome and the internal defence system of the snail
- (2015) Iman Fathy Abou-El-Naga et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study
- (2015) Maha M. Eissa et al. PLoS One
- Characterization of Celecoxib-Loaded Solid Lipid Nanoparticles Formulated with Tristearin and Softisan 100
- (2015) EA Fouad et al. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
- Demographic, socioeconomic and environmental changes affecting circulation of neglected tropical diseases in Egypt
- (2015) Iman F. Abou-El-Naga Asian Pacific Journal of Tropical Medicine
- Solid Lipid Nanoparticles and Nanostructured Lipid Carriers of Celecoxib for Topical Application – Preparation, Characterization and Drug Penetration Through Rat Skin
- (2014) Melike Üner et al. Current Nanoscience
- Absorption, Disposition and Pharmacokinetics of Solid Lipid Nanoparticles
- (2012) Jianping Qi et al. CURRENT DRUG METABOLISM
- Engineering solid lipid nanoparticles for improved drug delivery: promises and challenges of translational research
- (2012) Dinesh Kumar Mishra et al. Drug Delivery and Translational Research
- Angiogenesis and schistosomiasis
- (2010) Zilton A Andrade et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantel
- (2010) Ravi S. Kasinathan et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Solid lipid nanoparticles: A modern formulation approach in drug delivery system
- (2009) S Mukherjee et al. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility
- (2009) Shanta M. Messerli et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery
- (2008) Marc Muchow et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started